ABSTRACT
Background Chronic non-communicable disease comorbidities are a major problem faced by people living with HIV (PLHIV). Obesity is an important factor contributing to such comorbidities and PLHIV face an elevated risk of obesity. However, there is data paucity on the intersection of obesity and HIV in adolescents and youth living with HIV (AYLHIV) in sub-Saharan Africa. We therefore aimed to investigate the prevalence of abdominal obesity and associated multilevel factors in AYLHIV in peri-urban Cape Town, South Africa.
Methods We conducted a cross-sectional study enrolling AYLHIV aged 15 – 24 years attending primary healthcare facilities in peri-urban Cape Town in 2019. All measures, except for physical examination measures, were obtained via self-report using a self-administered electronic form. Our outcome of interest was abdominal obesity (waist-to-height ratio ≥ 0.5). We collected individual-level data and data on community, built and food environment factors. Data was summarized using descriptive statistics, stratified by sex. Multilevel logistic regression was conducted to investigate factors associated with abdominal obesity, adjusted for sex and age.
Findings A total of 87 participants were interviewed, 76% were female and the median age was 20.7 (IQR 18.9-23.0) years. More than two fifths had abdominal obesity (41%; 95% CI: 31.0-51.7%), compared to published rates for young people in the general population (13.7-22.1%). In multilevel models, skipping breakfast (aOR= 5.42; 95% CI: 1.32 – 22.25) was associated with higher odds of abdominal obesity, while daily wholegrain consumption (aOR= 0.20; 95% CI: 0.05 – 0.71) and weekly physical activity (aOR = 0.24; 95% CI: 0.06 – 0.92) were associated with lower odds of abdominal obesity. Higher anticipated stigma was associated with reduced odds of obesity (aOR= 0.58; 95% CI: 0.33 – 1.00). Land-use mix diversity (aOR= 0.52; 95% CI: 0.27 – 0.97), access to recreational places (aOR= 0.37; 95% CI: 0.18 – 0.74), higher perceived pedestrian and traffic safety (aOR= 0.20; 95% CI: 0.05 – 0.80) and having a non-fast-food restaurant within walking distance (aOR= 0.30; 95% CI: 0.10 – 0.93) were associated with reduced odds of abdominal obesity. The main limitations of the study were low statistical power and possible reporting bias from self-report measures.
Conclusions Our findings demonstrate a high prevalence of abdominal obesity and highlight multilevel correlates of obesity in AYLHIV in South Africa. An intersectoral approach to obesity prevention, intervening at multiple levels is necessary to intervene at this critical life stage.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by a Bristol-Myers Squibb Foundation grant awarded to TO (grant number 430960). https://www.bms.com/about-us/responsibility/bristol-myers-squibb-foundation/our-key-initiatives/secure-the-future.html TO is also funded by the National Institute for Health Research (NIHR) (16/137/34) using UK aid from the UK Government to support global health research. https://www.nihr.ac.uk/ MK was supported by the South African National Research Foundation (NRF: https://www.nrf.ac.za/) under joint funding with the German Academic Exchange Service (DAAD: https://www.daad.de/en/) for her PhD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical clearance was obtained from the Human Research Ethics Committee at the University of Cape Town (HREC ref no: 520/2017) and approval to access the facilities was obtained from Provincial and Local Government Departments of Health. Written informed consent (or assent with parental/ caregiver consent for participants less than 18 years old) was obtained for all participants.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.